Correcting and replacing navidea biopharmaceuticals reports third quarter 2022 financial results

Dublin, ohio--( business wire )--the seventh bullet under third quarter 2022 highlights and subsequent events should read: received an additional $1.0 million under a bridge loan from the company's vice chair of the board of directors, john k. scott, jr. (instead of: received an additional $1.5 million under a bridge loan from the company's vice chair of the board of directors, john k. scott, jr.).
NAVB Ratings Summary
NAVB Quant Ranking